GO:0015662 P-type ion transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015662 (P-type ion transporter activity) describes ATP-driven ion pumps that form a transient aspartyl-phosphate intermediate during each transport cycle.
• P-type ATPases are grouped into PIB-4 and other subtypes that move Zn2+, Cd2+, Co2+, Ni2+, Pb2+, Cu+, Ca2+, H+, Na+, and K+ across membranes.
• The catalytic cycle couples ATP hydrolysis to ion translocation through autophosphorylation, conformational switching (E1/E2), and counter-ion release.
• Loss of P-type ATPase function is linked to Wilson disease, lysosomal storage defects, and multidrug resistance in pathogens.
• Plant H+-ATPases and Ca2+-ATPases support growth, salt-alkaline tolerance, and stress responses.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to test causality of P-type ATPase genes in disease and physiology.
Description
P-type ion transporter activity (GO:0015662) is a molecular function that enables ATP-powered movement of ions across biological membranes through a phosphorylative mechanism. This activity is defined by the transient formation of a high-energy aspartyl-phosphoryl-enzyme intermediate, which distinguishes P-type ATPases from other ATP-driven transporters. The term covers a broad family of pumps, including PIB-4-type ATPases that export transition metals such as zinc, cadmium, cobalt, nickel, and lead. Because these transporters control essential ion gradients, they are central to physiology and disease. For example, the Na,K-ATPase maintains sodium and potassium gradients required for neuronal and muscle function, while plant H+-ATPases drive nutrient uptake and stress tolerance. In pathogens, P-type ATPases can contribute to multidrug efflux and survival inside hosts. Researchers study GO:0015662 to understand ion homeostasis, membrane energetics, and therapeutic targets. The function is experimentally monitored using solid supported membranes and other transport assays, and its dysfunction is implicated in Wilson disease, lysosomal disorders, and cancer-related pathways.
P-type ion transporter activity At A Glance
| GO ID | GO:0015662 |
|---|---|
| GO term | P-type ion transporter activity |
| Ontology | molecular_function |
| Synonym | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; ion transmembrane transporter activity, phosphorylative mechanism; P-type ATPase activity; zinc, cadmium, cobalt, nickel, lead-efflux ATPase activity |
| Major function | ATP-driven ion transport across membranes via a phosphorylated enzyme intermediate |
| Reaction | ATP + H2O = ADP + phosphate, coupled to ion movement |
| Key intermediate | Aspartyl-phosphoryl-enzyme intermediate |
| Representative ions | H+, Na+, K+, Ca2+, Cu+, Zn2+, Cd2+, Co2+, Ni2+, Pb2+ |
| Subtypes | Includes PIB-4-type ATPases and other P-type ATPase families |
What Is GO:0015662?
P-type ion transporter activity (GO:0015662) is an ATP-dependent molecular function in which a membrane-embedded protein moves one or more ions from one side of a membrane to the other. The reaction consumes ATP and water to produce ADP and phosphate, and it directly drives ion transport. A key feature is the transient formation of a high-energy aspartyl-phosphoryl-enzyme intermediate, meaning the transporter itself becomes phosphorylated on an aspartate residue during the cycle. This phosphorylative mechanism is the hallmark of P-type ATPases, which include ion pumps for H+, Na+, K+, Ca2+, Cu+, Zn2+, Cd2+, Co2+, Ni2+, and Pb2+.
Why Is P-type ion transporter activity Important in Cell Biology?
P-type ion transporter activity is essential because it establishes and maintains ion gradients that underlie nerve signaling, muscle contraction, nutrient uptake, pH regulation, and metal detoxification. Defects in these pumps cause or contribute to human diseases such as Wilson disease, lysosomal storage disorders, and drug-resistant infections. In plants, P-type ATPases support growth and survival under salt-alkaline stress. Therefore, understanding GO:0015662 provides mechanistic insight into physiology and offers targets for therapeutic intervention.
• Maintains electrochemical gradients for Na+, K+, H+, and Ca2+ that are required for nerve and muscle function.
• Enables transition-metal homeostasis and detoxification through PIB-4-type ATPases that export Zn2+, Cd2+, Co2+, Ni2+, and Pb2+.
• Supports plant growth, nutrient transport, and salt-alkaline stress responses via H+-ATPases and Ca2+-ATPases.
• Contributes to multidrug efflux and pathogen survival, as shown for the Mycobacterium tuberculosis zinc transporter Rv3270.
• Links to Wilson disease through copper(I)-binding and de-coppering mechanisms relevant to copper-transporting ATPases.
• Impacts lysosomal pH and hydrolase activity, as demonstrated for ATP13A2 loss and polyamine storage.
• Provides a druggable target class for cancer, neurodegeneration, and infectious disease research.
• Serves as a model system for studying phosphorylative transport mechanisms using solid supported membranes.
What Happens During P-type ion transporter activity?
Ion binding and E1 state formation
In simple terms: The pump opens toward one side of the membrane and grabs its target ion.
In the E1 state, the P-type ATPase exposes high-affinity ion-binding sites to the cytoplasm or the side from which ions are transported. For PIB-4-type ATPases, this step involves binding of transition-metal ions such as Zn2+, Cd2+, Co2+, Ni2+, or Pb2+. The Na,K-ATPase binds Na+ from the cytoplasm in its E1 conformation. This initial binding is coupled to the overall transport cycle and prepares the enzyme for phosphorylation.
ATP-dependent aspartyl phosphorylation
In simple terms: ATP donates a phosphate to the pump itself, creating a high-energy intermediate.
ATP binds to the cytoplasmic nucleotide-binding domain and transfers its terminal phosphate to a conserved aspartate residue, forming the aspartyl-phosphoryl-enzyme intermediate. This autophosphorylation step is the defining feature of P-type ATPases and distinguishes GO:0015662 from other ATPases. The reaction consumes ATP and water to produce ADP and phosphate, directly driving ion transport. Transport activity can be monitored using solid supported membranes that detect charge movement or current generated by the pump.
Conformational transition and ion release (E1 to E2)
In simple terms: The pump changes shape, moving the ion across the membrane and releasing it on the other side.
Phosphorylation drives a conformational change from E1 to E2, reducing ion affinity and opening the binding site to the opposite membrane side. For PIB-4-type ATPases, structural studies have revealed the ion-release pathway and the rearrangements that allow metal export. The Na,K-ATPase releases Na+ to the extracellular space and then binds K+ for the return cycle. This alternating-access mechanism is fundamental to P-type ion transport.
Dephosphorylation and resetting the cycle
In simple terms: The pump removes the phosphate, returns to its original shape, and is ready for another round.
Hydrolysis of the aspartyl-phosphate intermediate resets the enzyme to the E1 state, completing the cycle. Counter-ion binding and release are coordinated with dephosphorylation to ensure stoichiometric transport. In PIB-4-type ATPases, dephosphorylation is coupled to release of the transported metal ion. This catalytic cycle can be studied using biochemical assays and membrane-based electrophysiology.
Regulation by ions, pH, and cellular signals
In simple terms: The pump's speed and direction can be adjusted by the cell's environment and signals.
P-type ATPase activity is regulated by ion concentrations, pH, and post-translational modifications. Plant H+-ATPases are controlled by phosphorylation and 14-3-3 protein binding in response to stress and growth signals. Lysosomal ATP13A2 function is influenced by polyamine levels and lysosomal pH, which in turn affect hydrolase activity. These regulatory inputs allow cells to match ion transport to metabolic demand.
Key Genes Involved in GO:0015662 P-type ion transporter activity
The following genes and proteins represent major P-type ATPases and related factors that define or modulate GO:0015662.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP1A1 | Na,K-ATPase alpha-1 subunit; transports Na+ out and K+ into cells | Model for ion gradient maintenance and neuronal/muscle physiology |
| ATP2A1 | SERCA1 calcium pump in fast-twitch muscle | Calcium homeostasis and muscle function studies |
| ATP2B1 | Plasma membrane Ca2+-ATPase | Calcium signaling and cardiovascular research |
| ATP7A | Copper-transporting ATPase; Menkes disease gene | Copper homeostasis and neurodegeneration |
| ATP7B | Copper-transporting ATPase; Wilson disease gene | Copper(I)-binding and de-coppering drug studies |
| ATP13A2 | Lysosomal polyamine and metal transporter | Lysosomal pH, hydrolase activity, and neurodegeneration |
| Rv3270 | Mycobacterial P-type ATPase zinc transporter | Multidrug efflux and tuberculosis research |
| ZntA | Bacterial PIB-4-type Zn2+/Cd2+/Pb2+ ATPase | Structural and ion-release mechanism studies |
| CopA | Bacterial PIB-4-type Cu+ ATPase | Copper transport and metal resistance |
| HMA2 | Plant PIB-4-type Zn2+/Cd2+ ATPase | Metal homeostasis and phytoremediation |
| HMA4 | Plant PIB-4-type Zn2+/Cd2+ ATPase | Cadmium tolerance and metal distribution |
| AHA1 | Plant plasma membrane H+-ATPase | Growth, nutrient uptake, and stress responses |
| AHA2 | Plant plasma membrane H+-ATPase | Salt-alkaline stress and root acidification |
| GmCaATPase | Glycine soja Ca2+-ATPase | Salt-alkaline stress responses in legumes |
| SERCA2 | Sarcoplasmic/endoplasmic reticulum Ca2+-ATPase | Calcium cycling and cardiac function |
| ATP12A | Gastric H+/K+-ATPase | Acid secretion and ion transport studies |
| ATP4A | Gastric H+/K+-ATPase alpha subunit | Gastric acid regulation and drug targeting |
| ATP6 | Vacuolar-type H+-ATPase subunit (related but distinct) | Comparative studies of ATP-driven proton transport |
How Is P-type ion transporter activity Regulated?
P-type ion transporter activity is regulated at multiple levels. Ion concentrations and pH directly influence pump cycling and substrate availability. Post-translational modifications, including phosphorylation and 14-3-3 protein binding, control plant H+-ATPase activity during growth and stress. In lysosomes, ATP13A2 function is tied to polyamine storage and lysosomal pH, which can alter hydrolase-lipid interactions. Copper-transporting ATPases are regulated by copper availability and intracellular trafficking, which is relevant to Wilson disease and de-coppering strategies. In bacteria, P-type ATPases such as Rv3270 contribute to multidrug efflux and are likely regulated by metal and drug exposure. These layers of regulation allow cells to fine-tune ion transport according to metabolic and environmental demands.
P-type ion transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATP7B | Wilson disease; copper overload | Knockout or point-mutation hepatocyte models |
| ATP13A2 | Lysosomal storage and neurodegeneration | Knockout neurons or patient iPSC-derived neurons |
| Rv3270 | Multidrug resistance in tuberculosis | Mycobacterial knockout and efflux assays |
| ATP1A1 | Cardiac and neurological disorders | Knock-in or overexpression in cardiomyocytes |
| GmCaATPase | Salt-alkaline stress in legumes | Overexpression in Glycine soja or Arabidopsis |
Wilson disease and copper transport defects
Wilson disease is caused by mutations in ATP7B, a copper-transporting P-type ATPase. Studies of copper(I)-binding properties of de-coppering drugs, including alpha-lipoic acid, provide insight into therapeutic strategies for Wilson disease. These findings link GO:0015662 directly to copper homeostasis and liver/brain pathology.
Lysosomal dysfunction and neurodegeneration
Loss of ATP13A2, a lysosomal P-type ATPase, leads to polyamine storage and impaired beta-glucocerebrosidase activity through altered lysosomal pH and electrostatic hydrolase-lipid interactions. This mechanism connects P-type ion transport to lysosomal storage disorders and neurodegeneration.
Infectious disease and multidrug resistance
The Mycobacterium tuberculosis P-type ATPase Rv3270 enhances multidrug efflux activity, suggesting a role in drug resistance. Targeting such transporters may improve treatment outcomes in tuberculosis and other infections.
Plant stress and agricultural relevance
Plant P-type ATPases, including H+-ATPases and a Glycine soja Ca2+-ATPase, are involved in salt-alkaline stress responses and growth regulation. Understanding these pumps can inform crop improvement strategies for marginal soils.
From P-type ion transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATP7B cause copper accumulation? | CRISPR knockout in HepG2 or patient iPSCs |
| How does ATP13A2 affect lysosomal pH? | Knockout or point-mutation in neuronal cell lines |
| Does Rv3270 contribute to drug efflux? | Mycobacterial knockout and overexpression |
| What is the ion-release mechanism of PIB-4 ATPases? | Tagged knock-in for structural studies |
| How do plant H+-ATPases respond to salt stress? | Overexpression and knockout in Arabidopsis |
| Can a disease mutation be corrected? | Knock-in of wild-type or mutant alleles |
How to Study the P-type ion transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Solid supported membrane assay | Charge movement and transport activity | P-type ATPase functional characterization |
| Cryo-EM or crystallography | Protein structure and conformational states | Ion-release mechanism of PIB-4 ATPases |
| ATPase activity assay | ATP hydrolysis rate | Enzyme kinetics and inhibitor testing |
| Metal-binding assay | Copper(I) or other metal binding | Wilson disease drug studies |
| CRISPR knockout | Loss-of-function phenotype | Causal gene validation |
| Overexpression | Gain-of-function phenotype | Drug efflux and stress response |
| Lysosomal pH imaging | Lysosomal pH and hydrolase activity | ATP13A2-related neurodegeneration |
| Plant stress phenotyping | Growth under salt-alkaline conditions | H+-ATPase and Ca2+-ATPase studies |
Transport activity assays
P-type ATPase activity can be measured using solid supported membranes that detect charge movement or current generated by ion transport. These assays provide real-time readouts of pump function and are suitable for testing inhibitors or mutations.
Structural biology and ion-release mapping
Structural studies of PIB-4-type ATPases have revealed the ion-release pathway and conformational changes during the transport cycle. Such work informs mechanistic models and drug design targeting GO:0015662.
Biochemical and metal-binding assays
Copper(I)-binding properties of de-coppering drugs can be assessed using biochemical assays relevant to Wilson disease. Similar approaches can measure metal binding and transport for other P-type ATPases.
Cell-based and genetic screens
CRISPR knockout, point-mutation, and overexpression models allow researchers to test the causal role of P-type ATPase genes in disease phenotypes. Plant stress models can be used to study H+-ATPase and Ca2+-ATPase function.
How CRISPR Can Be Used to Study GO:0015662 P-type ion transporter activity
Knockout
CRISPR knockout of P-type ATPase genes such as ATP7B, ATP13A2, or Rv3270 can reveal loss-of-function phenotypes, including copper accumulation, lysosomal defects, or altered drug efflux. These models are essential for establishing causality in disease pathways.
Point Mutation
Introducing disease-associated point mutations into P-type ATPase genes allows researchers to study specific catalytic or regulatory defects, such as those affecting the aspartyl-phosphoryl intermediate or ion binding. This approach is valuable for modeling Wilson disease and other inherited disorders.
Knock-in
Knock-in of tagged or wild-type alleles can be used to track protein localization, measure transport activity, or correct mutations. Tagged knock-in models are particularly useful for structural and imaging studies of PIB-4-type ATPases.
Overexpression
Overexpression of P-type ATPases such as Rv3270 or plant H+-ATPases can enhance ion transport, drug efflux, or stress tolerance, providing gain-of-function evidence. These models help test therapeutic hypotheses and biotechnological applications.
How EDITGENE Supports P-type ion transporter activity Research
Researchers studying P-type ion transporter activity-related genes often need to determine whether a candidate gene is causally involved in ion homeostasis, disease, or stress responses. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for P-type ion transporter activity research.
Frequently Asked Questions About P-type ion transporter activity
What is P-type ion transporter activity?
P-type ion transporter activity (GO:0015662) is an ATP-driven molecular function that moves ions across membranes via a phosphorylated enzyme intermediate.
What genes are involved in P-type ion transporter activity?
Key genes include ATP1A1, ATP2A1, ATP7A, ATP7B, ATP13A2, Rv3270, ZntA, CopA, HMA2, HMA4, AHA1, AHA2, and GmCaATPase.
How does P-type ATPase work?
It binds an ion, autophosphorylates on an aspartate residue using ATP, changes conformation to release the ion, and dephosphorylates to reset the cycle.
What diseases are linked to P-type ion transporters?
They are linked to Wilson disease, lysosomal storage disorders, neurodegeneration, multidrug-resistant infections, and plant stress susceptibility.
What is the role of ATP7B in Wilson disease?
ATP7B is a copper-transporting P-type ATPase; its dysfunction causes copper overload, and de-coppering drugs are studied for treatment.
How is ATP13A2 related to lysosomal function?
Loss of ATP13A2 causes polyamine storage and impairs beta-glucocerebrosidase via altered lysosomal pH and hydrolase-lipid interactions.
Can CRISPR be used to study P-type ATPases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to test P-type ATPase gene function.
What methods measure P-type ATPase activity?
Solid supported membrane assays, ATPase activity assays, structural biology, and cell-based imaging are commonly used.
Why are P-type ATPases important in plants?
Plant H+-ATPases and Ca2+-ATPases support growth, nutrient uptake, and salt-alkaline stress responses.
How do P-type ATPases contribute to drug resistance?
Some bacterial P-type ATPases, such as Rv3270, enhance multidrug efflux and may promote survival during treatment.
Conclusion
P-type ion transporter activity (GO:0015662) is a fundamental ATP-driven mechanism that maintains ion gradients and metal homeostasis across all domains of life. Its dysfunction is implicated in Wilson disease, lysosomal disorders, neurodegeneration, and infectious disease, while plant P-type ATPases are critical for stress tolerance. Studying these transporters with CRISPR models and functional assays will continue to reveal therapeutic and biotechnological opportunities.
References
- 1. Chatterjee D et al.. 2024. P-type ATPase zinc transporter Rv3270 of Mycobacterium tuberculosis enhances multi-drug efflux activity.. Microbiology (Reading) 170(2) PMID: 38373028
- 2. Sun M et al.. 2016. Functional characterization of a Glycine soja Ca(2+)ATPase in salt-alkaline stress responses.. Plant Mol Biol 90(4-5):419-34 PMID: 26801329
- 3. Grønberg C et al.. 2021. Structure and ion-release mechanism of P(IB-4)-type ATPases.. Elife 10 PMID: 34951590
- 4. Samaddar M et al.. 2025. Lysosomal polyamine storage upon ATP13A2 loss impairs β-glucocerebrosidase via altered lysosomal pH and electrostatic hydrolase-lipid interactions.. Cell Rep 44(9):116179 PMID: 40848257
- 5. Kaplan JH. 2002. Biochemistry of Na,K-ATPase.. Annu Rev Biochem 71:511-35 PMID: 12045105
- 6. Tadini-Buoninsegni F. 2020. Protein Adsorption on Solid Supported Membranes: Monitoring the Transport Activity of P-Type ATPases.. Molecules 25(18) PMID: 32933017
- 7. Li Y et al.. 2022. H(+)-ATPases in Plant Growth and Stress Responses.. Annu Rev Plant Biol 73:495-521 PMID: 35231180
- 8. Smirnova J et al.. 2018. Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent.. Sci Rep 8(1):1463 PMID: 29362485
